Castillo Orive M - Search Results

1

Factors associated with disease progression in patients with atrial fibrillation and heart failure anticoagulated with rivaroxaban.

Manito N, Cepeda-Rodrigo JM, Farré N, Castillo Orive M, Galve E, Jiménez-Candil J, García-Pinilla JM, López Sánchez ES, Rafols C, Gómez Doblas JJ. Manito N, et al. Among authors: castillo orive m. Clin Cardiol. 2024 Feb;47(2):e24189. doi: 10.1002/clc.24189. Epub 2023 Nov 29. Clin Cardiol. 2024. PMID: 38018889 Free PMC article.

2

Impact of chronic kidney disease on use of evidence-based therapy in stable coronary artery disease: a prospective analysis of 22,272 patients.

Kalra PR, García-Moll X, Zamorano J, Kalra PA, Fox KM, Ford I, Ferrari R, Tardif JC, Tendera M, Greenlaw N, Steg PG; CLARIFY Investigators. Kalra PR, et al. PLoS One. 2014 Jul 22;9(7):e102335. doi: 10.1371/journal.pone.0102335. eCollection 2014. PLoS One. 2014. PMID: 25051258 Free PMC article.

3

Chronic coronary syndromes without standard modifiable cardiovascular risk factors and outcomes: the CLARIFY registry.

Roger G, Ducrocq G, Mesnier J, Sayah N, Abtan J, Ferrari R, Ford I, Fox KM, Tardif JC, Tendera M, Feldman LJ, Elbez Y, Steg PG; CLARIFY Investigators. Roger G, et al. Eur Heart J. 2024 Jul 12;45(27):2396-2406. doi: 10.1093/eurheartj/ehae299. Eur Heart J. 2024. PMID: 39193886

4

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

Sawhney JP, Kothiwale VA, Bisne V, Durgaprasad R, Jadhav P, Chopda M, Vanajakshamma V, Meena R, Vijayaraghavan G, Chawla K, Allu J, Pieper KS, John Camm A, Kakkar AK; GARFIELD-AF Investigators. Sawhney JP, et al. Indian Heart J. 2018 Nov-Dec;70(6):828-835. doi: 10.1016/j.ihj.2018.09.001. Epub 2018 Sep 12. Indian Heart J. 2018. PMID: 30580852 Free PMC article. Clinical Trial.

5

Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists.

Fitzmaurice DA, Accetta G, Haas S, Kayani G, Lucas Luciardi H, Misselwitz F, Pieper K, Ten Cate H, Turpie AG, Kakkar AK; GARFIELD-AF Investigators. Fitzmaurice DA, et al. Br J Haematol. 2016 Aug;174(4):610-23. doi: 10.1111/bjh.14084. Epub 2016 Apr 12. Br J Haematol. 2016. PMID: 27071942 Free article. Clinical Trial.

6

Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry.

Fauchier L, Greenlaw N, Ferrari R, Ford I, Fox KM, Tardif JC, Tendera M, Steg PG; CLARIFY Investigators. Fauchier L, et al. PLoS One. 2015 Apr 27;10(4):e0125164. doi: 10.1371/journal.pone.0125164. eCollection 2015. PLoS One. 2015. PMID: 25915904 Free PMC article.

7

Stable angina in Spain and its impact on quality of life. The AVANCE registry.

Borrás X, Garcia-Moll X, Gómez-Doblas JJ, Zapata A, Artigas R; AVANCE study researchers. Borrás X, et al. Rev Esp Cardiol (Engl Ed). 2012 Aug;65(8):734-41. doi: 10.1016/j.rec.2012.03.010. Epub 2012 Jun 26. Rev Esp Cardiol (Engl Ed). 2012. PMID: 22739550 English, Spanish.

8

Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.

Steg PG, Ferrari R, Ford I, Greenlaw N, Tardif JC, Tendera M, Abergel H, Fox KM; CLARIFY Investigators. Steg PG, et al. PLoS One. 2012;7(5):e36284. doi: 10.1371/journal.pone.0036284. Epub 2012 May 3. PLoS One. 2012. PMID: 22570699 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters